CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Product revenue, net	$ 341	$ 137	$ 1,004	$ 137
Operating expenses
Cost of goods sold	512	11	546	11
Research and development	19,619	22,062	74,392	58,780
Selling, general and administrative	24,344	17,054	73,810	48,097
Restructuring costs	4,163		4,163
Total operating expenses	48,638	39,127	152,911	106,888
Loss from operations	(48,297)	(38,990)	(151,907)	(106,751)
Other expense (income)
Interest expense	3,252	3,700	9,879	5,293
Interest income	(1,068)	(823)	(4,703)	(1,042)
Other expense (income), net	5	(62)	(286)	(53)
Net loss	$ (50,486)	$ (41,805)	$ (156,797)	$ (110,949)
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (1.72)	$ (1.49)	$ (5.40)	$ (3.96)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (1.72)	$ (1.49)	$ (5.40)	$ (3.96)
Weighted average shares outstanding - basic (in shares)	29,268	28,022	29,026	27,997
Weighted average shares outstanding - diluted (in shares)	29,268	28,022	29,026	27,997